Alere San Diego, Inc.

Alere San Diego, Inc., operating as Immunalysis Corporation, manufactures immunoassay reagent kits and diagnostic test products for controlled substance detection, serving federal defense and healthcare agencies as a prime contractor across 138 awards with no set-aside designations — full-and-open competition posture throughout. The company is a subsidiary of Abbott Laboratories, headquartered in Abbott Park, Illinois, and operates from Pomona, California. Alere San Diego competes without SBA certifications and across primary NAICS codes 541712 (In-Vitro Diagnostic Substance Manufacturing) and 333316 (Analytical Laboratory Instrument Manufacturing).

The customer concentration is heavily skewed toward the Department of Defense. The top five customers by award count account for 76 percent of recent awards, led by the Department of the Navy Bureau of Medicine and Surgery (57 awards, $15.9 million combined potential value) and the Office of the Secretary of Defense (14 awards, $52.6 million combined potential value). When ranked by potential value, OSD dominates with $52.6 million across 14 awards, while the Navy's 57 awards carry $15.9 million combined value. The Pretrial Services Agency ($6.2 million across 3 awards) and DOD Washington Headquarters Service ($5 million across 3 awards) represent the only meaningful civilian government exposure. Alere San Diego has worked with 18 distinct federal agencies, though Navy and OSD together account for approximately 65 percent of combined potential value.

Alere San Diego's capability portfolio centers on immunoassay reagent kits for opioid and controlled substance detection. Representative work includes a $651,223 firm fixed-price delivery order to the Air Education and Training Command (November 2021–September 2022) for fentanyl/norfentanyl immunoassay reagent kits; a $341,830 delivery order to the Defense Health Agency (April–May 2023) for fentanyl/norfentanyl immunoassay reagents supporting Tripler Army Medical Center in Hawaii; a $542,500 definitive contract with the Court Services and Offender Supervision Agency (August 2024–August 2029) for immunoassay reagents and oral fluid testing supplies for synthetic cannabinoids and fentanyl detection in urine and oral fluids; and multiple single-award indefinite delivery contracts with the Navy Bureau of Medicine and Surgery for 6-AM reagent kits ($750,102.21, awarded January 30, 2025, extending through January 29, 2030) and oxycodone/oxymorphone reagent kits ($907,680, awarded February 15, 2024, extending through June 14, 2030). The company also holds an FAA Non-Franchise Acquisition Services IDC ($85,923.57, awarded May 11, 2022, through July 13, 2027) for immunoassay reagents and equipment maintenance services performed in Oklahoma City.

Activity has accelerated markedly. Awards per year grew from 14 in 2022 to 26 in 2025, though 2026 is still early with only 4 awards recorded. The combined potential value across all 138 awards is $85.5 million, with $32.7 million (38 percent) obligated to date. Recompete exposure in the next twenty-four months is minimal — only 4 awards with $89 thousand combined potential value reach ultimate completion in that window. Five indefinite delivery contracts dominate the parent vehicle footprint: contract N6264520D5004 (39 task orders, $4.5 million), N0018924DZ013 (25 task orders, $372 thousand), N0018925DZ009 (16 task orders, $191 thousand), HQ003413D0005 (8 task orders, $8.8 million), and N6264523D5004 (6 task orders, $1.3 million). Work is performed across Pomona, California (primary manufacturing location), Oklahoma City (FAA maintenance support), and subordinate military medical facility locations nationwide and overseas (Fort Meade, Maryland; San Antonio, Texas; Hawaii; and others). The top product service code is In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (106 awards), with secondary work in laboratory equipment and supplies (20 awards) and equipment maintenance (8 awards).

Alere San Diego operates entirely as a prime contractor — no subcontract footprint appears in the federal award record. The company's parent, Abbott Laboratories, is a global healthcare manufacturer with extensive federal contracting reach; Alere San Diego functions as Abbott's specialized immunoassay reagent and diagnostic testing division serving the Department of Defense Drug Demand Reduction Program and military healthcare operations.